Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.62 (
caspase-9
)
7,507
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sialic acid binding immunoglobulin like lectin (Siglec)-8 crosslinking with specific antibodies causes human eosinophil apoptosis. Mechanisms by which
Siglec-8
crosslinking induces apoptosis are not known. Peripheral blood eosinophils were examined for caspase, mitochondria and reactive oxygen species (ROS) involvement after incubating the cells with anti-
Siglec-8
crosslinking Abs or control Abs, in the presence or absence of selective inhibitors.
Siglec-8
crosslinking induced rapid cleavage of caspase-3, caspase-8, and
caspase-9
in eosinophils. Selective caspase-8 and/or
caspase-9
inhibitors inhibited this apoptosis.
Siglec-8
crosslinking on eosinophils increased dissipation of mitochondrial membrane potential upstream of caspase activation. Rotenone and antimycin, inhibitors of mitochondrial respiratory chain components, completely inhibited apoptosis. Additional experiments with an inhibitor of ROS, diphenyleneiodonium, demonstrated that ROS was also essential for
Siglec-8
-mediated apoptosis and preceded
Siglec-8
-mediated mitochondrial dissipation. These experiments show that
Siglec-8
-induced apoptosis occurs through the sequential production of ROS, followed by induction of mitochondrial injury and caspase cleavage.
...
PMID:Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. 1615 3